Anyplex™II MTB/MDR Detection simultaneously detects and identifies Mycobacterium tuberculosis (MTB) and 25 mutations associated with MDR-TB. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this assay performs on multiplex real-time PCR instruments and provide prompt diagnosis and appropriate treatment guideline for tuberculosis control.
Wide range of applicable specimens
Simultaneous detection of Mycobacterium tuberculosis and 25 mutations associated with MDR-TB
WTC(Wild-type Control) and Internal Control (IC) for assay validity
Reagent for DNA Detection is provided, purchase of DNA extraction kit is unnecessary
Utilization of the UDG system to prevent carry-over contamination
Automated data interpretation and LIS interlocking with Seegene Viewer
Fast treatment decision by simultaneous screening and subtyping
Detection and identification of mutations associated antibiotic resistance for appropriate infection control
Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies
The results indicate the detection of MTB infection in the FAM channel, and the rifampicin-resistance mutation in the HEX channel and the Isoniazid-resistance mutation in the Cal Red 610 channel.